60889-33-0

Usage

Uses

Used in Pharmaceutical Industry:
Hexahydro-1H-furo[3,4-c]pyrrole hydrochloride is used as a reactant for the preparation of hexahydro-1H-furo[3,4-c]pyrrole compounds. These compounds have potential applications in the treatment of pain due to their ability to interact with specific biological targets, such as receptors or enzymes, involved in pain perception and transmission.
The use of Hexahydro-1H-furo[3,4-c]pyrrole hydrochloride in the pharmaceutical industry is primarily focused on the development of novel pain management therapies. By serving as a key reactant in the synthesis of hexahydro-1H-furo[3,4-c]pyrrole compounds, it contributes to the creation of new drug candidates with potential analgesic properties. These compounds may offer improved efficacy, reduced side effects, or alternative mechanisms of action compared to existing pain medications, ultimately benefiting patients suffering from various types of pain.

Upstream product

• 1221289-17-3 cis-5-benzyltetrahydro-1H-furo[3,4-c]pyrrole-1,3(3aH)-dione 
• 179601-65-1 cis-(1-benzylpyrrolidine-3,4-diyl)dimethanol 

Relevant academic research and scientific papers

An Approach to 3-Oxa-7-azabicyclo[33.0]octanes - Bicyclic Morpholine Surrogates

An approach to 3-oxa-7-azabicyclo[3.3.0]octanes, bicyclic morpholine analogues, is reported, which relies on [3+2] cycloaddition of maleic anhydrides or furan-2(5 H)-ones and an in situ generated azomethine ylide. The utility of the method was demonstrated on a multigram scale.

Hexahydro-1H-furo(3,4-c) pyrrole compounds for treating pain

Diclosed are compounds, having the following general formula, which are useful as analgesics and/or anti-inflammatory agents in living animals SPC1 Wherein R is a radical selected from the group consisting of hydrogen, aryl, alkenyl, aralkyl, halogen-substituted aralkyl, hydroxyl-substituted alkyl, arylsulfonyl, alicyclic, aroyl, alkylene dicarbonyl hexahydro-1H-furo (3,4-c)pyrrole, alkanoyl, arylene dicarbonyl hexahydro-1H-furo(3,4-c)pyrrole, halogen-substituted aroyl, arylethanoyl, halogen-substituted arylalkanoyl, halogen-substituted phenoxyalkanoyl, heteroaroyl, haloalkyl-substituted aroyl, alkyl-substituted aroyl, monoalkoxy-substituted aroyl, arylalkenoyl, hexahydrobenzoyl, alkanoyloxy-substituted aroyl, hydroxyl-substituted aroyl, and the pharmacologically acceptable acid addition salts thereof.